Elsevier Opens Books, Review Articles to Rare Disease Researchers... - Pulmonary Hypertension News

Elsevier Opens Books, Review Articles to Rare Disease Researchers... - Pulmonary Hypertension News

Elsevier Opens Books, Review Articles to Rare Disease Researchers... - Pulmonary Hypertension News

Posted: 03 Mar 2020 12:00 AM PST

Beginning on Feb. 29, Rare Disease Day, chapters from notable scientific books and clinical review articles covering rare disorders will be available free-of-charge from Elsevier.

The offer runs through April 30, and aims to supports work by researchers and clinicians into a better understanding of and treatments for rare diseases, as well as to raise awareness about these ills.

Elsevier — a science and health information analytics leader — has partnered with the research community for 140 years to curate and verify scientific knowledge.

The company's content helps clinicians and investigators identify the molecular mechanisms underlying rare diseases, advance therapy discovery, translate findings to the clinic, and counsel patients and families. Its articles feature a host of specific disorders, from rare mitochondrial diseases to autoimmune diseases.

Statistics indicate that about 95% of rare disorders, which impact an estimated 300 million people globally, have no approved treatments. For many of these diseases, diagnosis alone can be challenging. In addition, many patients find it difficult to access information about their disorder and quality healthcare.

"Diagnosis, patient care, and long-term management of patients with any of these 7,000 rare diseases can be confounding," Laura Colantoni, vice president of reference content at Elsevier, said in a press release.

"In offering this content, we hope to reinforce our commitment to supporting rare disease communities and individuals with rare disease, advancing rare disease research and empowering medical practice in this area," Colantoni added.

Taking place annually on the last day of February, Rare Disease Day is focused on raising awareness about rare diseases. The effort, which includes thousands of events worldwide, is coordinated by EURORDIS-Rare Diseases Europe.

Elsevier's Education, Reference, and Continuity Group is participating this year by offering free access to its published content, including book chapters and clinical review articles, on rare diseases.

Such content includes, from "Rare Diseases and Orphan Drugs," by Jules Berman (1st Edition):

Also available is Chapter 4 from "Genomic and Precision Medicine: Primary Care" by Thomas Morgan (3rd Edition), titled  "Genetic Testing for Rare and Undiagnosed Diseases."

Chapter 10, "The 'Life Costs' of Living with Rare Genetic Diseases," from "Genomics and Society" by Koichi Mikami, Alastair Kent, and Gill Haddow (1st Edition).

And Chapter 3 from "Applied Genomics and Public Health" by Gabriela M. Repetto and Boris Rebolledo-Jaramillo (1st Edition), titled "Rare Diseases: Genomics and Public Health."

Review articles on specific diseases can be accessed through Elsevier's Clinics Review Articles. Book content is available at Elsevier Life Sciences and Elsevier Health.

Journals published by Elsevier include "Applied and Translational Genomics," "Clinical Immunology," "Nanomedicine," and "The Journal of Immunology and Regenerative Medicine."

  • Author Details
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d'Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled "Belle of the Concours."
Total Posts: 329
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d'Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled "Belle of the Concours."
Latest Posts

Comments

Post a Comment

Popular posts from this blog

Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

Image
Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Posted: 11 Jul 2019 12:00 AM PDT For patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction, inhaled epoprostenol through high-flow nasal cannula increases oxygenation, according to a study published in Pharmaceutics . The researchers of this retrospective study assessed the effect of inhaled epoprostenol using a high-flow nasal cannula on oxygenation and future mechanical ventilation in patients with hypoxemia comorbid with pulmonary hypertension or right heart dysfunction in an intensive care unit setting. A chart review was completed on adult patients who were admitted into the respiratory care department of the Rush University Medical Center for severe hypoxemia between July 2015 and April 2018 and treated with inha...
Read more

Dyspnea (Shortness of Breath): Causes, Symptoms & Treatment - my.clevelandclinic.org

Image
Overview Shortness of breath (dyspnea) is most commonly caused by heart or lung conditions. Other causes include anemia, anxiety, lack of exercise or living with obesity. What is dyspnea (shortness of breath)? Dyspnea (pronounced "DISP-nee-uh") is the word healthcare providers use for feeling short of breath. You might describe it as not being able to get enough air ("air hunger"), chest tightness or working harder to breathe. Shortness of breath is often a symptom of heart and lung problems. But it can also be a sign of other conditions like asthma, allergies or anxiety. Intense exercise or having a cold can also make you feel breathless. What are paroxysmal nocturnal dyspnea (PND) and sighing dyspnea? Paroxysmal nocturnal dyspnea (PND) is a feeling like you can't breathe an hour or two after falling asleep. Sighing dyspnea is when you sigh a lot after taking deep breaths in to try to relieve the feeling of dyspnea. What is the differ...
Read more

What to Expect During Pulmonary Embolism Recovery - Healthline

Image
What to Expect During Pulmonary Embolism Recovery - Healthline What to Expect During Pulmonary Embolism Recovery - Healthline Pulmonary Arterial Hypertension: Updates in Epidemiology and Evaluation of Patients - AJMC.com Managed Markets Network Right-Sided Heart Failure: Symptoms, Causes, and Treatments - Healthline Right sided heart failure: Symptoms, outlook, treatment - Medical News Today What to Expect During Pulmonary Embolism Recovery - Healthline Posted: 19 May 2021 12:00 AM PDT A pulmonary embolism (PE) is when a blood clot becomes stuck in the blood vessels of your lung. These clots typically begin in the leg and then break free and travel to the lung. The American Lung Association estimates that about 1 in 1,000 people in the United States experience a PE each year. A PE can be a serious or life threatening condition, which means receiving prompt medical treatment is vital. Treatment of a PE focus...
Read more